Pegvisomant in Combination With Long-Acting Somatostatin Analogues in Acromegaly: The Role of the GH Receptor Deletion of Exon 3

European Journal of Endocrinology - United Kingdom
doi 10.1530/eje-15-0519
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bioscientifica

Related search

Prescription Patterns of Long-Acting Somatostatin Analogues

SAGE Open Medicine
Medicine
2017English

Glucose Homeostasis and Safety in Patients With Acromegaly Converted From Long-Acting Octreotide to Pegvisomant

Journal of Clinical Endocrinology and Metabolism
BiochemistryEndocrinologyClinical BiochemistryMedicineMetabolismDiabetes
2005English

Medical Treatment With Somatostatin Analogues in Acromegaly: Position Statement

The Korean Journal of Medicine
2019English

Efficacy of the New Long-Acting Formulation of Lanreotide (Lanreotide Autogel) in Somatostatin Analogue-Naive Patients With Acromegaly

Journal of Endocrinological Investigation
EndocrinologyMetabolismDiabetes
2009English

Cost-Effectiveness of Somatostatin Analogues for the Treatment of Acromegaly in Colombia

Open Journal of Endocrine and Metabolic Diseases
2012English

Combined Treatment for Acromegaly With Long-Acting Somatostatin Analogs and Pegvisomant: Long-Term Safety for Up to 4.5 Years (Median 2.2 Years) of Follow-Up in 86 Patients

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2009English

Effects of the Long-Acting Somatostatin Analogue Lanreotide Autogel on Glucose Tolerance and Insulin Resistance in Acromegaly

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2006English

Long-Term Treatment With Pegvisomant: Observations From 2090 Acromegaly Patients in ACROSTUDY.

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2018English

Interpreting Biochemical Control Response Rates With First-Generation Somatostatin Analogues in Acromegaly

Pituitary
EndocrinologyMetabolismDiabetes
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy